Literature DB >> 7694084

T cell clones specific for Bet v I, the major birch pollen allergen, crossreact with the major allergens of hazel, Cor a I, and alder, Aln g I.

C Ebner1, F Ferreira, K Hoffmann, R Hirschwehr, S Schenk, Z Szépfalusi, H Breiteneder, P Parronchi, S Romagnani, O Scheiner.   

Abstract

Tree pollens are responsible for type I allergies during the flowering season in spring. Pollens from birch, hazel and alder constitute the most important allergen sources in this respect in the northern hemisphere. Human IgE antibodies, specific for the major allergens of these pollens, are known to crossreact, and in general every tree pollen allergic patient is sensitized to these three pollen allergens. In this study we investigated eight T-helper cell clones (CD3+, CD4+, TCR alpha/beta) with specificity for Bet v I, the major birch pollen allergen, as proved by reactivity with purified natural as well as with recombinant allergen. The T cell clones were used to investigate common T cell epitopes of the Bet v I molecule with Cor a I, the major allergen of hazel pollen and Aln g I, the major allergen of alder pollen. All eight T cell clones reacted with all three proteins with different intensity. Moreover, three T cell clones, which were known to react with immunodominant T cell epitopes on the Bet v I molecule, were tested for reactivity with dodecapeptides synthesized according to the corresponding homologous regions of the Cor a I and Aln g I sequence. All the peptides induced strong T cell proliferation, indicating the existence of multiple cross-reacting epitopes. These findings will have an impact on the production of vaccines for immunotherapy of tree pollen allergies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694084     DOI: 10.1016/0161-5890(93)90093-q

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

Review 1.  Allergenic crossreactivities. Pollens and vegetable foods.

Authors:  R Fritsch; C Ebner; D Kraft
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

2.  Aerial pollen diversity in India and their clinical significance in allergic diseases.

Authors:  A B Singh; Pawan Kumar
Journal:  Indian J Clin Biochem       Date:  2004-07

3.  Alder pollen concentrations in the air during snowfall.

Authors:  I Kasprzyk; K Borycka
Journal:  Int J Biometeorol       Date:  2019-09-06       Impact factor: 3.787

4.  Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy.

Authors:  Erik Wambre; Jonathan H DeLong; Eddie A James; Rebecca E LaFond; David Robinson; William W Kwok
Journal:  J Allergy Clin Immunol       Date:  2011-10-05       Impact factor: 10.793

Review 5.  How Do Pollen Allergens Sensitize?

Authors:  Svetlana V Guryanova; Ekaterina I Finkina; Daria N Melnikova; Ivan V Bogdanov; Barbara Bohle; Tatiana V Ovchinnikova
Journal:  Front Mol Biosci       Date:  2022-06-16

6.  Diversity of TCRAV and TCRBV sequences used by human T-cell clones specific for a minimal epitope of Bet v 1, the major birch pollen allergen.

Authors:  H Breiteneder; O Scheiner; R Hajek; W Hulla; R Hüttinger; G Fischer; D Kraft; C Ebner
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

7.  Allergen hybrids - next generation vaccines for Fagales pollen immunotherapy.

Authors:  U Pichler; M Hauser; H Hofer; M Himly; E Hoflehner; M Steiner; S Mutschlechner; K Hufnagl; C Ebner; A Mari; P Briza; B Bohle; U Wiedermann; F Ferreira; M Wallner
Journal:  Clin Exp Allergy       Date:  2014-03       Impact factor: 5.018

8.  Identification of apple cultivars hypoallergenic for birch pollen-allergic individuals by a multidisciplinary in vitro and in vivo approach.

Authors:  Maria R Strobl; Ute Vollmann; Julia Eckl-Dorna; Astrid Radakovics; Verena Ibl; Madeleine Schnurer; Martin Brenner; Georgi Dermendjiev; Wolfram Weckwerth; Michael Neumüller; Florian Frommlet; Hilal Demir; Merima Bublin; Christian Müller; Barbara Bohle
Journal:  Clin Transl Allergy       Date:  2022-08       Impact factor: 5.657

9.  Simplified AIT for allergy to several tree pollens-Arguments from the immune outcome analyses following treatment with SQ tree SLIT-tablet.

Authors:  Peter Adler Würtzen; Pernille Milvang Grønager; Gitte Lund; Shashank Gupta; Peter Sejer Andersen; Tilo Biedermann; Henrik Ipsen
Journal:  Clin Exp Allergy       Date:  2020-12-08       Impact factor: 5.018

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.